Retirement, Money, And Rejuvenation Therapies

Low bond yields make retirement a dicey proposition. Consider again the 65-year-old couple who are starting to draw down $1 million in savings this year: if they withdrew 3 percent, or $30,000, a year, rather than that standard rate of 4 percent, inflation-adjusted, there is still a one-in-three chance that they will outlive their money, under current market conditions. Warning: this sort of projection is based on a business as usual (BAU) rate of progress in biomedical science. We are headed for a disruptive phase in development of biotechnology where we can begin to repair and replace aged tissue. Early stage rejuvenation therapies will arrive within the lifetimes of most people who are currently alive. But they will be expensive...
Source: FuturePundit - Category: Health Medicine and Bioethics Commentators Authors: Source Type: blogs